ZBIO ProShares UltraProShort Nasdaq BiotechnologyIt's a buy those who doesn't like to go short IBB
www.zacks.com
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−37.12 M USD
50.00 M USD
9.87 M
About Zenas BioPharma, Inc.
Sector
Industry
CEO
Leon Oliver Moulder
Headquarters
Waltham
Founded
2019
FIGI
BBG01J1MG9D6
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ZBIO is 12.04 USD — it has decreased by −14.14% in the past 24 hours. Watch Zenas BioPharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Zenas BioPharma, Inc. stocks are traded under the ticker ZBIO.
ZBIO stock has fallen by −39.59% compared to the previous week, the month change is a −42.89% fall, over the last year Zenas BioPharma, Inc. has showed a −34.39% decrease.
We've gathered analysts' opinions on Zenas BioPharma, Inc. future price: according to them, ZBIO price has a max estimate of 45.00 USD and a min estimate of 27.00 USD. Watch ZBIO chart and read a more detailed Zenas BioPharma, Inc. stock forecast: see what analysts think of Zenas BioPharma, Inc. and suggest that you do with its stocks.
ZBIO reached its all-time high on Feb 9, 2016 with the price of 50.95 USD, and its all-time low was 8.03 USD and was reached on Jan 29, 2018. View more price dynamics on ZBIO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ZBIO stock is 11.21% volatile and has beta coefficient of 2.20. Track Zenas BioPharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is Zenas BioPharma, Inc. there?
Today Zenas BioPharma, Inc. has the market capitalization of 520.17 M, it has decreased by −33.53% over the last week.
Yes, you can track Zenas BioPharma, Inc. financials in yearly and quarterly reports right on TradingView.
Zenas BioPharma, Inc. is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
ZBIO earnings for the last quarter are −5.02 USD per share, whereas the estimation was −0.95 USD resulting in a −427.90% surprise. The estimated earnings for the next quarter are −1.01 USD per share. See more details about Zenas BioPharma, Inc. earnings.
Zenas BioPharma, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ZBIO net income for the last quarter is −38.61 M USD, while the quarter before that showed −37.98 M USD of net income which accounts for −1.66% change. Track more Zenas BioPharma, Inc. financial stats to get the full picture.
No, ZBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ZBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zenas BioPharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.